Domesco Medical Import - Export Joint-Stock Corporation (HOSE:DMC)
Vietnam · Delayed Price · Currency is VND 57,500
+300 (0.52%)
At close: Aug 13, 2026
HOSE:DMC Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,126,667 | 2,067,317 | 1,899,427 | 1,719,032 | 1,592,727 | 1,498,395 | |
Revenue Growth | 6.44% | 8.84% | 10.49% | 7.93% | 6.30% | 3.20% |
Cost of Revenue | 1,690,932 | 1,658,209 | 1,481,947 | 1,346,931 | 1,139,838 | 1,096,779 |
Gross Profit | 435,735 | 409,108 | 417,480 | 372,101 | 452,889 | 401,616 |
Selling, General & Admin | 184,195 | 188,308 | 191,452 | 188,657 | 218,405 | 215,211 |
Operating Expenses | 184,195 | 188,308 | 191,452 | 188,657 | 218,405 | 215,211 |
Operating Income | 251,540 | 220,800 | 226,028 | 183,443 | 234,484 | 186,405 |
Interest Expense | -92.69 | -92.69 | - | - | - | - |
Interest & Investment Income | 30,797 | 26,785 | 25,044 | 40,645 | 18,977 | 11,612 |
Currency Exchange Gain (Loss) | 2,633 | -1,660 | 827.64 | 1,884 | -428.74 | 2,529 |
Other Non Operating Income (Expenses) | 291.88 | 596.81 | 862.48 | 2,895 | -2,942 | -1,486 |
EBT Excluding Unusual Items | 285,170 | 246,430 | 252,762 | 228,868 | 250,090 | 199,060 |
Gain (Loss) on Sale of Investments | 781.49 | 781.49 | 446.84 | 306.77 | 108.04 | 144.34 |
Gain (Loss) on Sale of Assets | 585.09 | 941.24 | 240.35 | - | - | - |
Pretax Income | 286,536 | 248,153 | 253,450 | 229,175 | 250,198 | 199,204 |
Income Tax Expense | 57,420 | 49,755 | 50,743 | 45,842 | 50,123 | 39,922 |
Net Income | 229,116 | 198,398 | 202,707 | 183,333 | 200,076 | 159,282 |
Preferred Dividends & Other Adjustments | 34,367 | 29,760 | 30,406 | 18,333 | 30,011 | 15,928 |
Net Income to Common | 194,749 | 168,638 | 172,301 | 164,999 | 170,064 | 143,354 |
Net Income Growth | 17.99% | -2.13% | 4.42% | -2.98% | 18.63% | -11.28% |
Shares Outstanding (Basic) | 35 | 35 | 35 | 35 | 35 | 35 |
Shares Outstanding (Diluted) | 35 | 35 | 35 | 35 | 35 | 35 |
Shares Change | -4.24% | - | - | - | - | - |
EPS (Basic) | 5607.92 | 4856.04 | 4961.51 | 4751.27 | 4897.12 | 4127.96 |
EPS (Diluted) | 5607.92 | 4856.00 | 4961.51 | 4751.00 | 4897.00 | 4127.96 |
EPS Growth | 23.21% | -2.13% | 4.43% | -2.98% | 18.63% | -11.28% |
Free Cash Flow | 43,476 | 124,657 | -25,925 | 141,611 | 263,124 | 156,331 |
Free Cash Flow Per Share | 1251.93 | 3589.59 | -746.53 | 4077.79 | 7576.83 | 4501.65 |
Dividend Per Share | - | - | 2500.000 | 2500.000 | 2500.000 | 2500.000 |
Dividend Growth | - | - | 0% | 0% | 0% | 0% |
Gross Margin | 20.49% | 19.79% | 21.98% | 21.65% | 28.43% | 26.80% |
Operating Margin | 11.83% | 10.68% | 11.90% | 10.67% | 14.72% | 12.44% |
Profit Margin | 9.16% | 8.16% | 9.07% | 9.60% | 10.68% | 9.57% |
Free Cash Flow Margin | 2.04% | 6.03% | -1.36% | 8.24% | 16.52% | 10.43% |
EBITDA | 271,925 | 239,550 | 243,358 | 202,431 | 254,184 | 210,551 |
EBITDA Margin | 12.79% | 11.59% | 12.81% | 11.78% | 15.96% | 14.05% |
D&A For EBITDA | 20,385 | 18,750 | 17,329 | 18,987 | 19,700 | 24,146 |
EBIT | 251,540 | 220,800 | 226,028 | 183,443 | 234,484 | 186,405 |
EBIT Margin | 11.83% | 10.68% | 11.90% | 10.67% | 14.72% | 12.44% |
Effective Tax Rate | 20.04% | 20.05% | 20.02% | 20.00% | 20.03% | 20.04% |
Revenue as Reported | 2,126,667 | 2,067,317 | 1,899,427 | 1,719,032 | 1,592,727 | 1,498,395 |
Advertising Expenses | - | 40,975 | 40,739 | - | 44,220 | 51,629 |